Based on the Sorrento Therape stock forecast from 0 analysts, the average analyst target price for Sorrento Therape is not available over the next 12 months. Sorrento Therape’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Sorrento Therape is Very Bullish, which is based on 2 positive signals and 0 negative signals. At the last closing, Sorrento Therape’s stock price was USD 0.00. Sorrento Therape’s stock price has changed by +0.00% over the past week, -28.57% over the past month and 0% over the last year.
No recent analyst target price found for Sorrento Therape
No recent average analyst rating found for Sorrento Therape
Company Overview Sorrento Therape
N/A
N/A
N/A
N/A
USD
USA
Adjusted Closing Price for Sorrento Therape (SRNE)
Loading...
Unadjusted Closing Price for Sorrento Therape (SRNE)
Frequently Asked Questions About Sorrento Therape (SRNE) Stock
Stock Target Advisor's fundamental analysis for Sorrento Therape's stock is Very Bullish.
Unfortunately we do not have enough data on SRNE's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on SRNE's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on SRNE's stock to indicate if its overvalued.
The last closing price of SRNE's stock was USD 0.00.
Unfortunately we do not currently have any market capitalization data for SRNE's stock.
Unfortunately we do not have enough analyst data on SRNE's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Sorrento Therape's stock.
Sorry, we do not have any data on the number of employees for Sorrento Therape.
Sorry we do not have any infomation available on Sorrento Therape's address.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
What not to like
There is nothing we particularly dislike
Frequently Asked Questions About Sorrento Therape (SRNE) Stock
Stock Target Advisor's fundamental analysis for Sorrento Therape's stock is Very Bullish.
Unfortunately we do not have enough data on SRNE's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on SRNE's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on SRNE's stock to indicate if its overvalued.
The last closing price of SRNE's stock was USD 0.00.
Unfortunately we do not currently have any market capitalization data for SRNE's stock.
Unfortunately we do not have enough analyst data on SRNE's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Sorrento Therape's stock.
Sorry, we do not have any data on the number of employees for Sorrento Therape.
Sorry we do not have any infomation available on Sorrento Therape's address.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for SRNE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
